When combined with clinical parameters from HNSCC tumors, we observed a further reduction of VENTXP1 expression in stage T3 and T4 versus that in stage T1 and T2 tumors (Fig. 2b). The gene discussed is VENTXP1; the disease is head and neck squamous cell carcinoma.